Scripps Health

 

Scripps Health
D

Diabetes Treatment in Patients With CVD and HF in 2021: SGLT-2 Inhibitors, GLP1-Receptor Agonists and Other Emerging Therapies

By Scripps Health FEATURING Daniel Einhorn
By Scripps Health FEATURING Daniel Einhorn
238 views
July 7, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

04:59
Merck

Clinical and Public Health Importance of Adult Pneumococcal Disease

Featured Video

05:09
Merck

Risk and Severity of Pneumococcal Disease in Adults

2021 Clinical Advances in Heart Failure and Arrhythmias
26:40
Scripps Health

His Bundle Pacing: How Effective Is It Compared to RV and BiV Pacing?

Feat. G. Dandamudi
23:26
Scripps Health

Gender Disparity in Cardiac Device Selection: Why Are Women Less Lik…

Feat. U. Birgersdotter-Green
16:11
Scripps Health

Lipoprotein(a) and Cardiovascular Disease: Prevalence, Biology of Lp…

Feat. C. Yeang
10:57
Scripps Health

Lp(a) Lowering Therapies: Are Statins, PCSK9i, Lipoprotein Apheresis…

Feat. C. Yeang
26:10
Scripps Health

Impact of Bariatric Surgery on Heart Failure: Can It Reduce In-Patie…

Feat. S. Bhoyrul
30:46
Scripps Health

Diabetes Treatment in Patients With CVD and HF in 2021: SGLT-2 Inhib…

Feat. D. Einhorn
22:55
Scripps Health

Geriatric Considerations in the Management of Heart Failure and Arrh…

Feat. J. Dodson
21:03
Scripps Health

Device Therapy Selection for Heart Failure in 2021: Pulmonary Artery…

Feat. A. Srivastava
20:35
Scripps Health

Intra-Atrial Shunt for the Treatment of Heart Failure: How Effective…

Feat. R. Mohan
39:03
Scripps Health

Fostering Heart Failure Expertise and Clinical Competencies for Adva…

Feat. K. Rasmusson